24 results
8-K
EX-99.3
ELTX
Elicio Therapeutics Inc.
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
for fast track designation, as well as intensive guidance on an efficient development program beginning as early as Phase 1 trials, and a commitment
S-4/A
EX-10.33
ELTX
Elicio Therapeutics Inc.
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
) the commission of any act of fraud, embezzlement or deliberate disregard of a rule or policy of the Company.
Time Commitment. Danforth will devote such time
S-4/A
EX-10.25
ELTX
Elicio Therapeutics Inc.
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
and diligent development of the Proposed Product, including a commitment to commercially reasonable development milestones. If M.I.T. approves … :
(a) Obtain the commitment of its SUBLICENSEES to use commercially reasonable diligent efforts to develop and commercialize LICENSED PRODUCTS in DEVELOPING
DEF 14A
52qpp
27 Apr 22
Definitive proxy
4:04pm
10-K
txt55b
30 Mar 21
Annual report
5:00pm
8-K
EX-3.2
jbqg341q09l0528
9 Feb 21
Entry into a Material Definitive Agreement
4:00pm
8-K
EX-10.1
qchzgk1hdm08e3sw
9 Feb 21
Entry into a Material Definitive Agreement
4:00pm
424B4
962g muy2
5 Feb 21
Prospectus supplement with pricing info
5:12pm
DRS/A
EX-3.1
061mtz
15 Dec 20
Draft registration statement (amended)
12:00am